P-158 (BREGO) Regorafenib combined with modified (m) GEMOX (Gemcitabine- Oxaliplatin) in patients with advanced biliary tract cancer (BTC): a phase Ib/II randomized trial

Author(s):

E. Assenat ◽

J.-P. Delord ◽

S. Thézenas ◽

E. Samalin ◽

F. Portales ◽

...

Keyword(s):

Randomized Trial ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Ib ◽

In Regard to “A Phase Ib Study of NUC ‐1031 in Combination with Cisplatin for the First‐Line Treatment of Patients with Advanced Biliary Tract Cancer ( ABC ‐08)”

The Oncologist ◽

10.1002/onco.13703 ◽

2021 ◽

Cited By ~ 3

Author(s):

Angela Dalia Ricci ◽

Alessandro Rizzo ◽

Giovanni Brandi

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Line Treatment ◽

First Line ◽

Phase Ib ◽

Tract Cancer ◽

First Line Treatment

2322 Safety and efficacy of Afatinib with Gemcitabine/Cisplatin in chemo-naïve patients with metastatic biliary tract cancer: An open-label, uncontrolled phase Ib trial

European Journal of Cancer ◽

10.1016/s0959-8049(16)31238-2 ◽

2015 ◽

Vol 51 ◽

pp. S440 ◽

Cited By ~ 2

Author(s):

M. Moehler ◽

A. Ehrlich ◽

C. Ruckes ◽

T. Thomaidis ◽

A. Weinmann ◽

...

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Open Label ◽

Safety And Efficacy ◽

Phase Ib ◽

Phase Ib study of binimetinib (MEK162) in combination with capecitabine in gemcitabine-pretreated advanced biliary tract cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.4079 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 4079-4079 ◽

Author(s):

Jin Won Kim ◽

Kyung-Hun Lee ◽

Ji-Won Kim ◽

Koung Jin Suh ◽

Ju-Hee Bang ◽

...

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Ib ◽

Brief Commentary: Largest Randomized Trial of Biliary Tract Cancer Treatment With Cisplatin Plus Gemcitabine Versus Gemcitabine Alone: An Excellent Opportunity to Evaluate the Prognostic Value of Tumor Marker CA 19-9

Clinical Colorectal Cancer ◽

10.3816/ccc.2011.n.012 ◽

2011 ◽

Vol 10 (1) ◽

pp. 70-71 ◽

Cited By ~ 2

Author(s):

M. Sitki Copur ◽

Angela Obermiller

Keyword(s):

Cancer Treatment ◽

Tumor Marker ◽

Randomized Trial ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Prognostic Value ◽

Tract Cancer ◽

Excellent Opportunity

A Phase Ib Study of NUC ‐1031 in Combination with Cisplatin for the First‐Line Treatment of Patients with Advanced Biliary Tract Cancer ( ABC ‐08)

The Oncologist ◽

10.1002/onco.13598 ◽

2020 ◽

Author(s):

Mairéad G. McNamara ◽

John Bridgewater ◽

Daniel H. Palmer ◽

Olusola Faluyi ◽

Harpreet Wasan ◽

...

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Line Treatment ◽

First Line ◽

Phase Ib ◽

Tract Cancer ◽

First Line Treatment

Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study

British Journal of Cancer ◽

10.1038/s41416-019-0523-5 ◽

2019 ◽

Vol 121 (4) ◽

pp. 332-339 ◽

Author(s):

Jin Won Kim ◽

Kyung-Hun Lee ◽

Ji-Won Kim ◽

Koung Jin Suh ◽

Ah-Rong Nam ◽

...

Keyword(s):

Cancer Patients ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Antitumor Effect ◽

Erk Pathway ◽

Phase Ib ◽

48P (BREGO) Regorafenib combined with modified m-GEMOX in patients with advanced biliary tract cancer (BTC): A phase II randomized trial

Annals of Oncology ◽

10.1016/j.annonc.2021.08.327 ◽

2021 ◽

Vol 32 ◽

pp. S376-S377

Author(s):

E. Assenat ◽

J.F. Blanc ◽

M. Bouattour ◽

L. Gauthier ◽

Y. Touchefeu ◽

...

Keyword(s):

Randomized Trial ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

A multicenter phase Ib-IIR trial assessing the activity of regorafenib combined with modified gemcitabine: Oxaliplatin (mGEMOX) in patients with advanced biliary tract cancer (aBTC).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e16134 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e16134-e16134 ◽

Author(s):

Eric Assenat ◽

Rosine Guimbaud ◽

Julien Fraisse ◽

Emmanuelle Samalin ◽

Fabienne Portales ◽

...

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Ib ◽

Tract Cancer ◽

Multicenter Phase

Selumetinib (Sel) and cisplatin/gemcitabine (CisGem) for advanced biliary tract cancer (BTC): A randomized trial.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.4084 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 4084-4084 ◽

Author(s):

Mark Doherty ◽

Vincent C. Tam ◽

Mairead Geraldine McNamara ◽

David W. Hedley ◽

Neesha C. Dhani ◽

...

Keyword(s):

Randomized Trial ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Multicentric Phase II Randomized Trial Comparing Chemoradiation (CHRT) with 5-Fluorouracil, Cisplatin (CDDP) and 50 GY versus Chemotherapy Alone (CH) with Gemcitabine (G) Plus Oxaliplatin (O) for Locally advanced Biliary Tract Cancer (FFCD9902)

Annals of Oncology ◽

10.1016/s0923-7534(20)33310-x ◽

2012 ◽

Vol 23 ◽

pp. ix242

Author(s):

J.M. Phelip ◽

V. Vendrely ◽

J. Jouve ◽

F. Subtil ◽

M. Gasmi ◽

...

Keyword(s):

Randomized Trial ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Locally Advanced ◽